The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD)....
A rare disease diagnosis for a loved one can be devastating. The majority of rare diseases are pediatric, meaning they affect children from birth or early...
A diverse scientific community is essential to create and advance the biomedical breakthroughs that are so urgently needed in our complex and evolving world. In this...
Rare diseases are anything but rare – with more than 7,000 uniquely identified, they cumulatively affect more than 300 million patients worldwide. The majority of these...
We are pleased to announce that Marissa Scavuzzo, PhD, a 2019 NYSCF–Druckenmiller Fellow, is a recipient of the Hanna H. Gray fellowship award. The Howard Hughes...
The Context: Human bone requires a certain environment within the body to grow, and recreating this environment outside of the body has enormous potential for understanding...
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
There is finally a light at the end of the COVID-19 pandemic tunnel, thanks to a historic vaccine development effort. What will it take to bring...
The New York City Economic Development Corporation (NYCEDC) announced an investment in four new biotech research and development facilities, including the NYSCF Research Institute. This grant...
After a long 10 months, COVID-19 vaccines are finally here. The next obstacle? Determining how to distribute them efficiently, ethically, and economically. Last week, experts in...
The Context: Neuromuscular disorders such as ALS arise from degeneration of brain cells that send signals to the muscles, and there are no treatments that address...
Watch the Fireside Chat video and read the summary below. After a historic research effort, COVID-19 vaccines are already here. Several of these vaccines, including the...
The Context: Prosthetic implants are regularly used in dentistry and orthopedics, and there are an estimated 2 million Americans living with limb loss today. Most prosthetic...
The Context: Scientists have long known that octopuses are able to taste what they touch with their tentacles, but the way their tentacles sense taste has...
The Context: The choroid plexus is a brain structure that makes cerebrospinal fluid (CSF): liquid that bathes the brain and spinal cord to form a protective...
2020 has been a year like no other. The COVID-19 pandemic has presented the world with unparalleled challenges and has highlighted the need for pioneering biomedical...
Racial and ethnic minorities are disproportionately affected by virtually every major disease of our time, and this gap has only been exacerbated by COVID-19. This year,...
Ezogabine (an epilepsy drug), has successfully reduced a hallmark of ALS in 65 patients participating in a phase 2 clinical trial, according to a recent report...
Cover photo: Dr. Valentina Fossati (NYSCF) and Jason Stein (Aspen Neuroscience) prepare cells for launch. Photo credit: Space Tango Why send cells affected by multiple sclerosis...
The Context: All of our blood cells — including our immune cells — come from a special type of stem cells known as ‘hematopoietic stem cells’...
Drugs that aim to treat Parkinson’s disease (PD) have not fared well in clinical trials, suggesting that there is more to PD than we currently understand....
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
The Context: CRISPR gene editing holds a great deal of promise for correcting disease-causing mutations in humans, potentially as early as during embryonic development. However, before...
The Context: 1 in 3,000 people has a genetic defect called 22q11.2 deletion syndrome, or 22q11DS, putting them at a greater risk for developing schizophrenia. However,...
